Glenmark Pharma to raise over Rs 1,300 cr via bonds issuance to repay debt

New Delhi: Drug firm Glenmark Pharmaceuticals Monday said it plans to raise around $200 million (around Rs 1,341 crore) by issuing dollar denominated non-convertible unsecured bonds to repay debt.

GlenmarkRecalledBirthPills_PicUS-FDA

"Glenmark Pharmaceuticals Ltd has decided to tap into the International Bond market and is planning to raise around $200 mn by issuing USD denominated non-convertible unsecured bonds," the company said in a BSE filing.

It further said: "The net proceeds will be used for repaying the existing debt. These bonds are planned to be listed on the Singapore Stock Exchange in order to establish the company's track record in the globally recognized bond market".

Shares of Glenmark Pharmaceuticals Ltd were trading 1.04 percent lower at Rs 843 on BSE.


Updated Date: Jul 18, 2016 11:27 AM

Also Watch

IPL 2018: Royal Challengers Bangalore eye revival against Chennai Super Kings as 'Cauvery Derby' comes back to life
  • Thursday, April 26, 2018 In the Kanjarbhat community, a campaign against 'virginity tests' is slowly gaining ground
  • Tuesday, April 24, 2018 It's A Wrap: Beyond the Clouds stars Ishaan Khatter, Malavika Mohanan in conversation with Parul Sharma
  • Monday, April 9, 2018 48 hours with Huawei P20 Pro: Triple camera offering is set to redefine smartphone imaging
  • Monday, April 16, 2018 Rajyavardhan Singh Rathore interview: Sports can't be anyone's fiefdom, we need an ecosystem to nurture raw talent

Also See